Reported Standalone quarterly numbers for Vivimed Labs are:
Net Sales at Rs 33.00 crore in June 2023 down 30.33% from Rs. 47.36 crore in June 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 15.38 crore in June 2023 up 29.72% from Rs. 21.89 crore in June 2022.
EBITDA stands negative at Rs. 0.28 crore in June 2023 up 96.69% from Rs. 8.45 crore in June 2022.
Vivimed Labs shares closed at 4.95 on July 31, 2023 (NSE) and has given -52.40% returns over the last 12 months.
Story continues below Advertisement
| Vivimed Labs | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'23 | Mar'23 | Jun'22 | | Net Sales/Income from operations | 33.00 | 39.72 | 47.36 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 33.00 | 39.72 | 47.36 | | EXPENDITURE | | Consumption of Raw Materials | 17.72 | 22.75 | 27.91 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.16 | 159.25 | 0.34 | | Power & Fuel | -- | -- | -- | | Employees Cost | 6.57 | 7.92 | 5.66 | | Depreciation | 4.49 | 95.07 | 4.23 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 9.16 | 13.58 | 21.98 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -4.78 | -258.84 | -12.76 | | Other Income | 0.01 | -- | 0.08 | | P/L Before Int., Excpt. Items & Tax | -4.77 | -258.84 | -12.68 | | Interest | 10.61 | 8.07 | 9.26 | | P/L Before Exceptional Items & Tax | -15.38 | -266.91 | -21.94 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -15.38 | -266.91 | -21.94 | | Tax | -- | -2.07 | -0.05 | | P/L After Tax from Ordinary Activities | -15.38 | -264.85 | -21.89 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -15.38 | -264.85 | -21.89 | | Equity Share Capital | 16.58 | 16.58 | 16.58 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.86 | -31.94 | -2.65 | | Diluted EPS | -1.80 | -31.01 | -2.56 | | EPS After Extra Ordinary | | Basic EPS | -1.86 | -31.94 | -2.65 | | Diluted EPS | -1.80 | -31.01 | -2.56 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
